International Stem Cell CORP (ISCO) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $9.10M | +0.2% |
| 2024 | $9.09M | +16.6% |
| 2023 | $7.79M | -4.8% |
| 2022 | $8.18M | +14.0% |
| 2021 | $7.18M | +0.7% |
| 2020 | $7.13M | -24.7% |
| 2019 | $9.47M | -14.6% |
| 2018 | $11.09M | +48.7% |
| 2017 | $7.46M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $9.10M | +0.2% |
| 2024 | $9.09M | +16.6% |
| 2023 | $7.79M | -4.8% |
| 2022 | $8.18M | +14.0% |
| 2021 | $7.18M | +0.7% |
| 2020 | $7.13M | -24.7% |
| 2019 | $9.47M | -14.6% |
| 2018 | $11.09M | +48.7% |
| 2017 | $7.46M | — |